The NHS spent £21.6bn on medicines in 2024–25 — a bill now under threat as the Iran war disrupts Gulf shipping and Middle East air hubs, squeezing supply chains and risking higher costs and shortages for drugs and medical equipment. The service also spends roughly £8bn a year on equipment and consumables, many of which are made from petrochemicals such as syringes, IV bags and single‑use devices. NHS Supply Chain has boosted stocks amid the logistics disruption, and NHS England chief Jim Mackey told the Health Service Journal he is "very worried" about the potential financial hit.

How petrochemicals feed the hospital budget Modern healthcare depends on materials that start as oil and gas. Petrochemicals are turned into plastics, fibres and chemical feedstocks used in active pharmaceutical ingredients and in millions of sterile single‑use items. Examples include: - latex gloves, catheter components and syringe barrels - IV bags and other fluid containers - diagnostic housings and components for stents and prosthetic hips These production chains are invisible inside wards but visible on hospital purchase orders. The NHS is one of the largest bulk buyers in the world: in 2024–25 it paid £21.6bn for medicines and roughly £8bn for equipment and consumables, according to NHS procurement figures cited by The Guardian. That scale gives the health service buying power — but it also concentrates risk. NHS Supply Chain manages sourcing and delivery for more than 620,000 product lines. When a single upstream shock affects raw materials used across thousands of SKUs, the knock‑on is rapid and wide. War, chokepoints and the cargo routes that matter The immediate disruption is logistical. Much petrochemical feedstock and finished medical kit moves through the Persian Gulf, where shipping standstills or damage to energy infrastructure can delay shipments. At the same time, airports in the Middle East — notably Dubai and Doha — are key transhipment hubs for medicines flown from India, which supplies large volumes of off‑patent drugs. Airlines have been cutting flights amid concerns about jet fuel access and airspace safety. That dual hit — sea and air — raises the chance of shortages and forces buyers to reroute or charter freight at higher cost. “You’ve got this dual problem of the airspace and the knock‑on problems around logistic chains,” said Richard Sullivan, professor of cancer and global health at King’s College London and director of the Institute of Cancer Policy, describing how fragile many cancer and other drug supply lines are. For some cancer medicines the chain is thin and relies on a single supplier; when movement of active ingredients and finished products is delayed, hospitals can struggle to maintain treatment schedules. Procurement responses and the financial trade‑offs Procurement teams have been building buffers. NHS Supply Chain’s head of resilience, Tom Brailsford, said stocks have been increased “where appropriate” and the organisation has been pressing suppliers on continuity plans and alternative logistics routes. Those moves reduce clinical risk but come at a price: - buying earlier ties up cash - air freight and alternative shipping raise unit costs - larger inventories increase storage and expiry risks Jim Mackey, chief executive of NHS England, told Health Service Journal he is “very worried” about supply challenges and warned that if the war produces a “huge shock” of price rises the NHS will need additional funding from government. Managers face a stark choice: absorb rising costs inside existing budgets and reduce other services, or seek extra public money to cover the shortfall. Where costs will show up in the accounts Price pressure will appear in two places on NHS balance sheets: higher purchase prices for medicines and consumables, and increased logistics and holding costs as organisations reroute freight and build stock buffers.

Related Articles

Jim Mackey said he is "very worried" about the supply‑chain challenges and warned the health service may require extra government funding if the conflict causes a large rise in prices.

This article was created with AI assistance.